BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 7840295)

  • 1. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.
    Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction.
    Tofukuji M; Stahl GL; Agah A; Metais C; Simons M; Sellke FW
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):1060-8. PubMed ID: 9832699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitation of myocardial infarct size in pigs with a dual lipoxygenase-cyclooxygenase blocking agent by inhibition of neutrophil activity without reduction of neutrophil migration.
    Amsterdam EA; Pan HL; Rendig SV; Symons JD; Fletcher MP; Longhurst JC
    J Am Coll Cardiol; 1993 Nov; 22(6):1738-44. PubMed ID: 8227848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8.
    Ivey CL; Williams FM; Collins PD; Jose PJ; Williams TJ
    J Clin Invest; 1995 Jun; 95(6):2720-8. PubMed ID: 7769111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function.
    Simpson PJ; Todd RF; Mickelson JK; Fantone JC; Gallagher KP; Lee KA; Tamura Y; Cronin M; Lucchesi BR
    Circulation; 1990 Jan; 81(1):226-37. PubMed ID: 2153476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization.
    Riley RD; Sato H; Zhao ZQ; Thourani VH; Jordan JE; Fernandez AX; Ma XL; Hite DR; Rigel DF; Pellas TC; Peppard J; Bill KA; Lappe RW; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):350-8. PubMed ID: 10917953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C5a-induced myocardial ischemia: role for CD18-dependent PMN localization and PMN-platelet interactions.
    Fletcher MP; Stahl GL; Longhurst JC
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1750-61. PubMed ID: 7902015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.
    Pachel C; Mathes D; Arias-Loza AP; Heitzmann W; Nordbeck P; Deppermann C; Lorenz V; Hofmann U; Nieswandt B; Frantz S
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):629-35. PubMed ID: 26916731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary C5a induces myocardial ischemia by mechanisms independent of the neutrophil: leukocyte filters desensitize the myocardium to C5a.
    Engler RL; Roth DM; del Balzo U; Ito BR
    FASEB J; 1991 Nov; 5(14):2983-91. PubMed ID: 1661246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion.
    Liu X; Huang Y; Pokreisz P; Vermeersch P; Marsboom G; Swinnen M; Verbeken E; Santos J; Pellens M; Gillijns H; Van de Werf F; Bloch KD; Janssens S
    J Am Coll Cardiol; 2007 Aug; 50(8):808-17. PubMed ID: 17707188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury.
    Lefer DJ; Shandelya SM; Serrano CV; Becker LC; Kuppusamy P; Zweier JL
    Circulation; 1993 Oct; 88(4 Pt 1):1779-87. PubMed ID: 8104739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnolol reduces myocardial ischemia/reperfusion injury via neutrophil inhibition in rats.
    Lee YM; Hsiao G; Chen HR; Chen YC; Sheu JR; Yen MH
    Eur J Pharmacol; 2001 Jun; 422(1-3):159-67. PubMed ID: 11430926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion.
    Zhao ZQ; Nakamura M; Wang NP; Velez DA; Hewan-Lowe KO; Guyton RA; Vinten-Johansen J
    J Surg Res; 2000 Dec; 94(2):133-44. PubMed ID: 11104653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular Unloading Increases the Coronary Collateral Flow Index Before Reperfusion and Reduces Infarct Size in a Swine Model of Acute Myocardial Infarction.
    Briceno N; Annamalai SK; Reyelt L; Crowley P; Qiao X; Swain L; Pedicini R; Foroutanjazi S; Jorde L; Yesodharan G; Perera D; Kapur NK
    J Am Heart Assoc; 2019 Nov; 8(22):e013586. PubMed ID: 31698989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA).
    Zhao L; Kirsch CC; Hagen SR; Elliott GT
    J Mol Cell Cardiol; 1996 Jan; 28(1):197-208. PubMed ID: 8745227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.
    Zhao ZQ; Corvera JS; Halkos ME; Kerendi F; Wang NP; Guyton RA; Vinten-Johansen J
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H579-88. PubMed ID: 12860564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion.
    Simpson PJ; Fantone JC; Mickelson JK; Gallagher KP; Lucchesi BR
    Circ Res; 1988 Dec; 63(6):1070-9. PubMed ID: 2461814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloricromene reduces infarct size and alters postischaemic blood flow defects in dog myocardium.
    Groban L; Zvara DA; Deal DD; Vernon JC; Flye CW; Ma XL; Vinten-Johansen J
    Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):417-23. PubMed ID: 9673816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion.
    Aversano T; Zhou W; Nedelman M; Nakada M; Weisman H
    J Am Coll Cardiol; 1995 Mar; 25(3):781-8. PubMed ID: 7860929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.